The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma
Official Title: A Phase 2, Multicenter, Open-label, Single Arm Study of Lenalidomide (CC-5013) in Combination With Low-dose Dexamethasone in Japanese Patients With Previously Untreated Multiple Myeloma
Study ID: NCT01698801
Brief Summary: To determine the efficacy of lenalidomide in combination with low-dose dexamethasone in Japanese subjects with previously untreated multiple myeloma.
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan
Nagoya City University Hospital, Nagoya, Aichi, Japan
Kameda Medical Center, Kamogawa, Chiba, Japan
Japanese Red Cross Narita Hospital, Narita, Chiba, Japan
Ehime University Hospital, Touon, Ehime, Japan
Nishigunma National Hospital, Shibukawa, Gunma, Japan
Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
Hitachi General Hospital, Hitachi, Ibaraki, Japan
Iwate Medical University, Morioka, Iwate, Japan
Tokai University Hospital, Isehara, Kanagawa, Japan
Tohoku University Hospital, Sendai, Miyagi, Japan
Kurashiki Central Hospital, Kurashiki, Okayama, Japan
Kinki University Hospital, Faculty of Medicine, Osakasayama, Osaka, Japan
Shizuoka Cancer Center, Sunto, Shizuoka, Japan
National Disaster Medical Center, Tachikawa, Tokyo, Japan
Kagoshima Medical Center, Kagoshima, , Japan
University Hospital, Kyoto Prefectural University of Medicine, Kyoto, , Japan
Niigata Cancer Center Hospital, Niigata, , Japan
Okayama Medical Center, Okayama, , Japan
Osaka Red Cross Hospital, Osaka, , Japan
National Cancer Center Hospital, Tokyo, , Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, , Japan
Japanese Red Cross Medical Center, Tokyo, , Japan
Keio University Hospital, Tokyo, , Japan
Name: Toru Sasaki
Affiliation: Celgene K.K.
Role: STUDY_DIRECTOR